Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | -2.08% | +2.17% | +13.20% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.20% | 38.62M | |
+4.85% | 109B | |
+11.44% | 105B | |
-0.35% | 22.25B | |
-12.10% | 22.09B | |
-7.91% | 18.68B | |
-38.36% | 17.58B | |
-10.16% | 16.85B | |
+4.58% | 13.76B | |
+35.75% | 12.46B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Needham Adjusts OncoCyte's Price Target to $4 From $5, Citing Peer Multiple Compression; Buy Rating Kept